Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novavax Inc
(NQ:
NVAX
)
9.120
-0.230 (-2.46%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novavax Inc
< Previous
1
2
3
4
5
6
7
8
9
...
55
56
Next >
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
October 26, 2024
Knowing these will help you avoid making suboptimal investing decisions.
Via
The Motley Fool
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
October 21, 2024
Let's look beyond this piece of bad news from regulators.
Via
The Motley Fool
How Bad Is This News for Novavax?
October 19, 2024
Novavax stock fell 20% in one trading session on the news.
Via
The Motley Fool
Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 16, 2024
On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates
October 16, 2024
Via
Benzinga
Here's How Much $1000 Invested In Novavax 5 Years Ago Would Be Worth Today
October 02, 2024
Via
Benzinga
Looking Into Novavax's Recent Short Interest
October 01, 2024
Via
Benzinga
$1000 Invested In Novavax 5 Years Ago Would Be Worth This Much Today
September 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
October 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
October 16, 2024
Novavax stock dips as the FDA pauses its COVID-19-influenza vaccine trials following a serious adverse event.
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 16, 2024
Via
Benzinga
What's Going On With Novavax Stock Today?
October 09, 2024
Novavax Inc (NASDAQ:NVAX) shares are bouncing around Wednesday, pulling back after popping in early trading. The company announced that it received European marketing authorization for its Nuvaxovid...
Via
Benzinga
Exposures
COVID-19
How Is The Market Feeling About Novavax?
September 04, 2024
Via
Benzinga
Looking Into Novavax's Recent Short Interest
August 16, 2024
Via
Benzinga
RPM International Posts Upbeat Earnings, Joins Joby Aviation, Ciena And Other Big Stocks Moving Higher On Wednesday
October 02, 2024
Via
Benzinga
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
October 01, 2024
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds.
Via
Talk Markets
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration urges healthcare providers to prioritize alternative vaccines for seniors and...
Via
Benzinga
Exposures
COVID-19
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
The biotech continues to earn important wins, but is it enough?
Via
The Motley Fool
Why Are Novavax Shares Trading Lower Today?
September 12, 2024
Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know.
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
September 06, 2024
Here's a look at five stocks that saw increased attention from Benzinga readers during the week and the reasons why.
Via
Benzinga
Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?
September 05, 2024
Regulators recently approved an updated COVID shot from Novavax.
Via
The Motley Fool
Exposures
COVID-19
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
September 03, 2024
Via
Benzinga
FDA Approves Novavax's Updated COVID Vaccine Targeting Currently Circulating Variants
September 03, 2024
The FDA granted Emergency Use Authorization to Novavax's updated COVID-19 vaccine for individuals aged 12 and older. The vaccine, included in CDC recommendations, will soon be available nationwide....
Via
Benzinga
Exposures
COVID-19
Product Safety
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
August 24, 2024
Don't be too quick to jump on the Wall Street bandwagon.
Via
The Motley Fool
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
August 22, 2024
The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to...
Via
Benzinga
Exposures
COVID-19
Product Safety
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
August 19, 2024
Its 12-month relative strength performance is impressive, but Novavax now faces resistance.
Via
Investor's Business Daily
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
August 19, 2024
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
Via
Benzinga
Topics
ETFs
Exposures
COVID-19
Product Safety
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
August 08, 2024
Novavax reported Q2 2024 revenue of $415 million, missing estimates, with net income rising to $162 million. EPS increased to $0.99, below expectations. The company revised its 2024 revenue guidance to...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.